Cancer Research News: October 23 – November 5

  • University of Michigan researchers are studying which populations of gut bacteria are closely linked with colon cancer.
  • A single dose of HPV vaccine may be enough to enable long term protection against new HPV infections, and ultimately, cervical cancer.
  • A team of researchers in Cambridge, Mass. have used genomic profiling to identify potential targets for pediatric cancer treatments.
  • Cancer vaccines are turning out to be effective for some advanced cancers that have limited treatment options, like lymphoma and inoperable pancreatic cancer.

MSKCC in the News: October 17 – October 31

  • Phys.org reported on research recently published in an article in Nature Chemical Biology on work by a collaborative team of scientists from MSKCC, the Broad Institute, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital, that outlines how they built a new cell culture model that mimics AML in its niche in the bone marrow and makes the search for promising new drugs more effective.
  • PMLive reported that the non-profit Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will bring together scientists from MSKCC, Rockefeller University and Weill Cornell Medical College and will focus on basic research and early-stage drug discovery up to the ‘proof-of-concept’ stage.
  • The Wall Street Journal announced that MSKCC has placed Gelclair(R) on its formulary as the exclusive therapeutic to treat oral mucositis (OM).

Blog Buzz: October 1 – October 25

A government shutdown and Open Access week, lots of excitement for this edition of Blog Buzz!

There is/was no shortage of posts on how the government shutdown impacted science and made it harder to find certain types of information. Thankfully, the shutdown itself is behind us, but here are a few of those posts:

And here are a few in honor of Open Access week:

  • Science magazine had a special issue Communication in Science: Pressures and Predators with free news and reviews on the lack of scrutiny at open-access journals, the rarity of published negative studies, and publishing sensitive data. Do you agree?
  • Curt Rice takes issue with one of the pieces in Science Who’s afraid of peer review?, over on the Guardian, saying the peer review system has broken down and that is the real issue. Peter Suber weighs in to dispel six myths about OA also at the Guardian.
  • Sally Gore writes on this year’s OA week theme of altmetrics, and the altmetrics she is waiting for…the ones to help measure and communicate the value of librarians.

And some more about scholarly communication…

  • Nature News reports that on October 22nd, the NCBI launched the pilot phase of PubMed Commons, a platform being designed to let researchers comment on published works under their real names. Will there be enough participation for it be a successful new arena for discussion? Perhaps if it does it can help address the problems below…
  • From the Economist, a brief item about fraudulent academic publishing in China, fueled in part by a distorted ranking system that prizes quantity over quality.